Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,859 public trials 2,108 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Completed

A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer

NCT02231723

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +17 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Emory University Winship Cancer Institute Atlanta, Georgia, United States
  • Parkview Research Center Fort Wayne, Indiana, United States
  • Indiana University Health Goshen Center for Cancer Care Goshen, Indiana, United States
View Trial Details
Completed

Recurrence After Whipple's (RAW) Study

NCT04596865

Conditions
Adenocarcinoma, Ampullary Cancer, Bile Duct Cancer, +35 more
Locations
  • Monash Medical Centre Clayton, Victoria, Australia
  • Medical University Innsbruck, Anichstr. 35 A Innsbruck, Austria
  • Azienda Ospedaliero - Universitaria Di Sassari Sassari, Sardinia, Italy
  • Azienda Ospedaliero - Universitaria Policlinico Umberto I Rome, Italy
View all 29 locations
View Trial Details
Completed

A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation

NCT03684811

Conditions
Adenocarcinoma, Astrocytoma, Bile Duct Diseases, +25 more
Locations
  • Banner MD Anderson Gilbert, Arizona, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • University of Miami, Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Northwestern University, Lurie Comprehensive Cancer Center Chicago, Illinois, United States
View all 26 locations
View Trial Details
Completed

A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma

NCT02993731

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Ductal, +12 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Clearview Cancer Institute (CCI) Huntsville, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
View all 267 locations
View Trial Details
Completed

A Study to Assess the Safety and Efficacy of Lenvatinib as First-line Treatment in Participants With Unresectable HCC

NCT04297254

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations
  • HCG Comprehensive Cancer Care Hospital Bangalore, Karnataka, India
  • Tata Memorial Hospital Mumbai, Maharashtra, India
  • HCG Manavata Cancer Centre Nashik, Maharashtra, India
  • Shatabdi Hospital Nashik, Maharashtra, India
View Trial Details
Completed

A Study of BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients With Hepatocellular Carcinoma

NCT02279719

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • Southern California Research Center Coronado, California, United States
  • California Center Associates for Research and Excellence, Inc. (Ccare) Encinitas, California, United States
View all 29 locations
View Trial Details

Related conditions